Research location
Holešov
Czechia
Advertisement
Research activity in Holešov
CzechiaCureCurrent currently publishes aggregate city-level research activity for this location: 28 trials and 29 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Holešov
28 linked trials · page 1 of 1A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinNCT07392190 · 2026-02-10 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorNCT06065540 · 2023-09-27 · 1 site observation
COMPLETED
Investigational Study of Delayed Release MetforminNCT04854512 · 2021-05-18 · 1 site observation
SUSPENDED
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesNCT04707469 · 2021-01-15 · 1 site observation
COMPLETED
Gan & Lee Evaluation of New Biosimilar for Type 1 LisproNCT04254380 · 2019-12-04 · 1 site observation
WITHDRAWN
A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin GlargineNCT03922750 · 2019-05-09 · 1 site observation
COMPLETED
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerNCT03663569 · 2018-08-15 · 2 site observations
COMPLETED
Gan & Lee Insulin Glargine Target Type (1) Evaluating ResearchNCT03371082 · 2017-10-31 · 1 site observation
COMPLETED
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic AgentsNCT03285594 · 2017-09-15 · 1 site observation
COMPLETED
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)NCT02580591 · 2015-12-22 · 1 site observation
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusNCT02597049 · 2015-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 1 site observation
COMPLETED
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusNCT02091362 · 2014-03-01 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled AsthmaNCT01730027 · 2013-04-01 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinNCT01499082 · 2011-12-01 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01468987 · 2011-12-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)NCT01075282 · 2010-02-01 · 1 site observation
COMPLETED
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusNCT01029795 · 2010-02-01 · 1 site observation
TERMINATED
Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin AloneNCT00995345 · 2009-10-01 · 1 site observation
COMPLETED
A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsNCT00666718 · 2008-04-01 · 1 site observation
COMPLETED
Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of LifeNCT00619177 · 2007-03-01 · 1 site observation
COMPLETED
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFONCT00362323 · 2006-10-01 · 1 site observation
COMPLETED
First Presentation of Parkinson Disease Patients to NeurologistNCT00802178 · 2006-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.